Enlimomab
Based on 1 Customer Validation
Enlimomab (BI-RR 0001), a murine IgG2a monoclonal antibody to the human ICAM-1, inhibits leukocyte adhesion to the vascular endothelium, thereby decreasing leukocyte extravasation and inflammatory tissue injury. Enlimomab has anti-inflammatory effects, and can be used for stroke research .
For research use only. We do not sell to patients.
- Purity : 95.00%
- CAS No.: 142864-19-5
- Molecular Weight:147.1 kDa
-
Storage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
ICAM1/CD54
In Vitro
In whole blood, Enlimomab activates resting neutrophils in a complement-dependent manner[1] .
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Flow Cytometry analysis of Raji cells labelling ICAM1/CD54 (red) with Enlimomab (anti-ICAM1/CD54) (HY-P99336). Goat Anti-Human IgG (Alexa Fluor 488) (HY-P83776) at a dilution of 1/1000 was used as the secondary antibody. Blue-Mouse IgG2a kappa (HY-P99978). Black-Unlabelled control, cells without incubation with primary antibody.
Product Details
-
CAS No. 142864-19-5
-
Accession P05362
-
Synonyms BI-RR 0001; Anti-Human IL6 Recombinant Antibody
-
Molecular Weight 147.1 kDa
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
Mouse IgG2a kappa
-
Recommend Isotype Controls
-
Format
-
IgG2a-nd
-
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Purity
95.00%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Shipping
Shipping with dry ice.
Purity & Documentation
References
[1]. J Vuorte, et al. Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood. J Immunol. 1999 Feb 15;162(4):2353-7. [Content Brief]
[2]. [2]Gregory J del Zoppo. Acute anti-inflammatory approaches to ischemic stroke. Ann N Y Acad Sci. 2010 Oct;1207:143-8. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)